Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

RAY1225

Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight

Guangdong Raynovent Biotech Co · Phase 3 · Recruiting · Enrollment 640

NCT06893016

ArmPopulationDoseWeeksEstimandWeight change
RAY1225 High DoseObesity or overweightn/rn/rn/rn/r
RAY1225 Medium DoseObesity or overweightn/rn/rn/rn/r
RAY1225 Low DoseObesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r